Uday Kompella - 25 Oct 2021 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role: Director
Signature: /s/ Uday Kompella by Sanjay Subramanian, his attorney-in-fact
Issuer symbol: OCGN
Transactions as of: 25 Oct 2021
Transactions value $: -$722,299
Form type: 4
Filing time: 27 Oct 2021, 16:55:17 UTC
Previous filing: 22 Oct 2021
Next filing: 03 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCGN	Common Stock	Sale	-$421K	-46.4K	-16.81%	$9.08^*	229K	25 Oct 2021	By: Kompella LLC	F1, F2
transaction	OCGN	Common Stock	Sale	-$301K	-25K	-10.9%	$12.05^*	204K	26 Oct 2021	By: Kompella LLC	F1
holding	OCGN	Common Stock						551K	25 Oct 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.00 to $9.36. The Reporting Person undertakes to provide to Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.00 to $9.36. The Reporting Person undertakes to provide to Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.